DNAG Stock Overview

Engages in the development and marketing of genetic testing products and services. More details

DNAG fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($1K)

Latest financial reports are more than a year old

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

DNAPrint Genomics, Inc. Competitors

eFFECTOR Therapeutics

OTCPK:EFTR

US$940.0

Molecular Templates

OTCPK:MTEM

US$2.0k

Gritstone bio

OTCPK:GRTS.Q

US$147.0

DermTech

OTCPK:DMTK.Q

US$35.0

Price History & Performance

Summary of share price highs, lows and changes for DNAPrint Genomics
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.00013
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	0%
3 Year Change	0%
5 Year Change	0%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	DNAG	US Biotechs	US Market
7D	0%	-1.1%	-0.3%
1Y	0%	-2.3%	20.4%

Return vs Industry: DNAG matched the US Biotechs industry which returned 0.9% over the past year.

Return vs Market: DNAG underperformed the US Market which returned 22% over the past year.

Price Volatility

Is DNAG's price volatile compared to industry and market?
DNAG volatility
DNAG Average Weekly Movement	n/a
Biotechs Industry Average Movement	11.3%
Market Average Movement	6.0%
10% most volatile stocks in US Market	18.5%
10% least volatile stocks in US Market	3.0%

Stable Share Price: DNAG's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine DNAG's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1983	n/a	n/a	n/a

DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients.

DNAPrint Genomics, Inc. Fundamentals Summary

How do DNAPrint Genomics's earnings and revenue compare to its market cap?
DNAG fundamental statistics
Market cap	US$1.29k
Earnings (TTM)	-US$4.55m
Revenue (TTM)	US$1.93m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is DNAG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DNAG income statement (TTM)
Revenue	US$1.93m
Cost of Revenue	US$1.48m
Gross Profit	US$446.37k
Other Expenses	US$5.00m
Earnings	-US$4.55m

Last Reported Earnings

Sep 30, 2007

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did DNAG perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/07 17:06
End of Day Share Price	2025/01/31 00:00
Earnings	2007/09/30
Annual Earnings	2006/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DNAPrint Genomics, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.